EP 1251829 A4 20090506 - ELECTROSPUN PHARMACEUTICAL COMPOSITIONS
Title (en)
ELECTROSPUN PHARMACEUTICAL COMPOSITIONS
Title (de)
ELEKTROGESPONNENE PHARMAZEUTISCHE ZUBEREITUNGEN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES SOUMISES AU FILAGE ELECTRIQUE
Publication
Application
Priority
- US 0102399 W 20010125
- US 17868200 P 20000128
Abstract (en)
[origin: WO0154667A1] The present invention is directed to an electrospun pharmaceutical composition comprising a pharmaceutically acceptable actibe agent, and a pharmaceutically acceptable polymeric carrier for use in therapy.
IPC 1-7
IPC 8 full level
A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61K 45/00 (2006.01); A61K 47/08 (2006.01); A61K 47/14 (2006.01); A61K 47/20 (2006.01); A61K 47/24 (2006.01); A61K 47/30 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2006.01); A61P 1/00 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 3/14 (2006.01); A61P 5/14 (2006.01); A61P 5/16 (2006.01); A61P 5/18 (2006.01); A61P 5/24 (2006.01); A61P 5/38 (2006.01); A61P 7/02 (2006.01); A61P 7/04 (2006.01); A61P 7/10 (2006.01); A61P 9/06 (2006.01); A61P 9/08 (2006.01); A61P 9/12 (2006.01); A61P 11/14 (2006.01); A61P 21/02 (2006.01); A61P 25/02 (2006.01); A61P 25/08 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/06 (2006.01); A61P 31/12 (2006.01); A61P 33/10 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); A61P 39/02 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR)
A61K 9/145 (2013.01 - EP); A61K 47/50 (2017.07 - KR); A61P 1/00 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 3/14 (2017.12 - EP); A61P 5/14 (2017.12 - EP); A61P 5/16 (2017.12 - EP); A61P 5/18 (2017.12 - EP); A61P 5/24 (2017.12 - EP); A61P 5/38 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 7/04 (2017.12 - EP); A61P 7/10 (2017.12 - EP); A61P 9/06 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/14 (2017.12 - EP); A61P 21/02 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/06 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 33/10 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 39/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); D01D 5/0023 (2013.01 - EP); D01D 5/0038 (2013.01 - EP); D01F 1/10 (2013.01 - EP)
Citation (search report)
- [E] WO 0127365 A1 20010419 - UNIV AKRON [US], et al
- [XD] WO 8808298 A1 19881103 - FUISZ RICHARD C [US]
- See references of WO 0154667A1
Citation (examination)
US 4043331 A 19770823 - MARTIN GRAHAM ERNEST, et al
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0154667 A1 20010802; AR 028204 A1 20030430; AU 3113401 A 20010807; AU 772830 B2 20040506; BR 0107869 A 20021105; CA 2396640 A1 20010802; CN 1223340 C 20051019; CN 1396823 A 20030212; EP 1251829 A1 20021030; EP 1251829 A4 20090506; HU P0301130 A2 20030929; HU P0301130 A3 20060728; IL 150642 A0 20030212; JP 2003521493 A 20030715; KR 100806412 B1 20080221; KR 20020082212 A 20021030; MX PA02007298 A 20021209; MY 129356 A 20070330; NO 20023338 D0 20020711; NO 20023338 L 20020903; NZ 519992 A 20040430; PL 356924 A1 20040712; TW I289061 B 20071101; ZA 200205989 B 20030203
DOCDB simple family (application)
US 0102399 W 20010125; AR P010100354 A 20010126; AU 3113401 A 20010125; BR 0107869 A 20010125; CA 2396640 A 20010125; CN 01804242 A 20010125; EP 01903299 A 20010125; HU P0301130 A 20010125; IL 15064201 A 20010125; JP 2001555646 A 20010125; KR 20027009477 A 20020724; MX PA02007298 A 20010125; MY PI20010355 A 20010126; NO 20023338 A 20020711; NZ 51999201 A 20010125; PL 35692401 A 20010125; TW 90101371 A 20010207; ZA 200205989 A 20020726